glp-1 claim GLP-1s prescriptions for weight loss are skyrocketing in North Carolina GLP-1 supplement claims: Regulatory considerations

For type 2 diabetes management , NICE guideline NG28 recommends considering GLP-1 receptor agonists when: Triple therapy with metformin and two other oral medications is ineffective, not tolerated or contraindicated The patient has a body mass index (BMI) of 35 kg/m or higher (with lower thresholds for people from certain ethnic backgrounds), or lower BMI with specific clinical circumstances where weight loss would benefit other obesity-related comorbidities Insulin would have significant occupational implications GLP-1 therapy should only be continued beyond six months if there has been a beneficial metabolic response, defined as a reduction in HbA1c of at least 11 mmol/mol (1.0 percentage point) and weight loss of at least 3% of initial body weight

Your provider will evaluate your unique health needs to determine if GLP-1 drugs is the right treatment for you

Yes, in most cases if theyre within 12 months

You need a valid prescription from a licensed provider and a 503A pharmacy to fill it, and most of these platforms handle both inside one checkout

Adherence challenges are not unique to GLP-1s